Cognitive Impairment in Juvenile Myoclonic Epilepsy by Kim, Sun-Young et al.
- 86 -
Journal of Clinical Neurology / Volume 3 / June, 2007 Original Articles
Cognitive Impairment in Juvenile Myoclonic Epilepsy 
Sun-Young Kim, M.D.
a, Yang-Ha Hwang, M.D.
a, Ho-Won Lee, M.D.
a, 
Chung-Kyu Suh, M.D.
a, Soon-Hak Kwon, M.D.
b, Sung-Pa Park, M.D.
a 
Departments of 
aNeurology and 
bPediatrics, School of Medicine, Kyungpook National University, Daegu, Korea
Background and Purpose: Cognitive impairments are frequent consequences of epilepsy, with intellectual ability 
reportedly being lower in patients with idiopathic generalized epilepsies than in the general population. However, 
neuropsychological investigations have been rarely performed in patients with juvenile myoclonic epilepsy (JME). We 
aimed to quantify the cognitive function in JME patients using various neuropsychological tests.
Methods: We compared cognitive function in 27 JME patients with that in 27 healthy volunteers using tests 
examining cognitive performance, such as the verbal and visual memory, frontal function, attention, IQ score, and 
mood. In the JME group, we examined risk factors for cognitive function such as age, sex, family history, education 
level, age at seizure onset, seizure frequency, EEG abnormality, disease duration, and previous intake of antie-
pileptic drugs.
Results: Verbal learning was significantly lower in JME patients than in controls, and attention and verbal fluency 
were impaired in JME patients compared with controls. However, general intellectual ability and mood did not differ 
between the groups. Early onset of seizure and long duration of disease were closely related to impaired cognitive 
function.
Conclusions: JME patients may exhibit impaired cognitive function, in terms of memory and execution, despite 
having normal intelligence and mood.
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INTRODUCTION
A significant proportion of patients with epilepsy are 
at an increased risk of cognitive impairment.
1,2,10  General 
mental slowness, memory impairment, and attention 
problems are the most common deficits in epilepsy 
patients.
5 Neuropsychology has made a major contri-
bution to characterizing cognition in different types of 
epilepsy and epileptic syndromes. Most previous investi-
gations have concentrated on determining the localiza-
tion and lateralization of the epileptogenic abnormality 
in adult patients with focal epilepsies (mesial temporal 
lobe epilepsy).
20 Interest has recently shifted to neuro-
psychological investigations of nonlesional, so-called 
idiopathic epilepsies, which have identified specific 
cognitive and behavioral disturbances that may provide 
clues concerning the underlying pathogenic process and 
the potential compensatory mechanisms that are induced.
3
Juvenile myoclonic epilepsy (JME) is the most impor-
tant syndrome of idiopathic generalized epilepsy (IGE), 
and has been associated with frontal lobe dysfunction in 
recent studies using neuropsychological tests
21  and various 
neuroimaging modalities.
6–8,27  Furthermore, JME is report-Kim SY, et al. Cognitive Impairment in Juvenile Myoclonic Epilepsy 
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edly associated with minimal global cognitive dysfunc-
tion, based on neuropsychological tests
4 and MRI 
volumetry.
9 Although two neuropsychological studies 
have demonstrated the presence of cognitive dysfunction 
in JME patients, the significance of the results obtained 
may be diminished by the use of confined neuro-
psychological tests, epilepsy patients as a control group, 
medication with antiepileptic drugs (AEDs) before the 
investigation, and no consideration of psychosocial 
factors such as mood in the cognitive evaluation.
4,21
The aim of this study was to quantify cognitive dys-
function in JME patients who did not take AEDs before 
the investigation. We applied several neuropsychological 
tests (including mood tests) to JME patients and age-and 
education-matched healthy subjects. 
MATERIALS AND METHODS
1. Subjects 
Twenty-seven patients with JME were consecutively 
enrolled. The inclusion criteria of JME were as follows: 
juvenile onset of myoclonic jerks on awakening with or 
without generalized tonic-clonic seizure, generalized dis-
charges of an irregular mixture of 3–6 Hz spiking/ 
polyspiking slow waves on EEG, no intake of AEDs for 
at least 6 months prior to the study commencing, older 
than 16 years, and education minimum of primary school 
completion. The exclusion criteria were progressive 
neurological disorders, head injury, mental retardation 
(IQ score below 70), alcohol or drug abuse, ongoing use 
of any centrally acting medications, severe psychiatric 
problems, and other severe medical disorders. We also 
excluded patients who had a generalized seizure within 
the previous week or myoclonic jerks within the pre-
vious 24 hours.
Twenty-seven age-and education-matched subjects 
were consecutively collected as a control group during 
the enrollment of JME patients. The controls had no 
neurological or psychiatric illness, no family history of 
seizures, no history of medication, and an IQ score 
greater than 70.
2. Neuropsychological tests
Neuropsychological tests were administered in a 
sound-attenuated, temperature-controlled room by a 
single examiner. According to the literature and our own 
clinical experience, we selected two cognitive measures 
that are particularly sensitive to epilepsy patients.
25,38  We 
assessed the memory function through list learning, 
immediate and delayed word recall, word recognition, 
and visual reproduction based on the Memory Assess-
ment Scale, which was obtained from Psychological 
Assessment Resources.
11  We assessed attention deficit 
using forward and backward digit spans from the 
Wechsler Memory Scale-Revised.
12 We examined atten-
tion, visuomotor tracking abilities, and mental flexibility 
using the Trail-Making Test (TMT) from the Halstead- 
Reitan Battery.
13 We studied verbal fluency using se-
mantic fluency tests from the Boston Diagnostic Aphasia 
Examination–Third Edition.
14 We assessed the general 
intelligence using a short form of the Korean version of 
the Wechsler Adult Intelligence Scale.
29 We also evalu-
ated mood states using the Beck Depression Inventory 
(BDI)
15 and Beck Anxiety Inventory (BAI).
28 Testing 
sessions lasted about 50 minutes. If a seizure occurred 
during a neuropsychological examination, testing was 
suspended and the obtained data were excluded from 
subsequent analyses.
3. Study design
We evaluated differences in cognition, mood states, 
and intelligence between the JME and control groups. In 
the JME group, we examined risk factors for cognitive 
function such as age, sex, family history, education level, 
age at seizure onset, seizure frequency, EEG abnor-
mality, disease duration, and previous intake of AEDs.
4. Statistical analysis
Higher scores indicate better performance on all of 
the cognitive tests employed except for the TMT (parts 
A and B), for which higher scores indicate a poorer 
performance because the time required is defined as the 
dependent measure in these tests. The data for conti-Journal of Clinical Neurology: Vol. 3, No. 2, 2007
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Table 1. Characteristics of juvenile myoclonic epilepsy (JME) patients and controls
JME (n=27) Controls (n=27) Significance
a
Age, years, mean (range) 19.2 (16–29) 20.3 (16–27) NS*
Sex, male, % 67 63 NS
Education, %
Graduated from primary school 19 11 NS
Graduated from high school  81 89 NS
Age at onset, years, mean (range) 16.3 (12–23)
Duration of epilepsy, years, mean (range) 2.9 (0.4–9)
Newly diagnosed with epilepsy within previous 3 months, % 81
Family history, % 22
Seizure rate in previous 3 months, seizures/month, mean (range) 2.0 (0.3–10)
at test for independent samples (two-sided) and Fisher’s exact test. 
*Nonsignificant (NS), p>0.05. 
nuous variables are expressed as mean±SD values, and 
the data for categorized variables are expressed as fre-
quencies. We used the t test for independent samples to 
compare neuropsychological scores. Fisher’s exact test 
was used for categorized variables, and Pearson’s corre-
lation test was used to assess correlations between neuro-
psychological scores, patient characteristics, and epilepsy 
variables.
RESULTS
1. Intergroup differences
The characteristics of patient and controls are listed in 
Table 1. Age, gender, and education level did not differ 
significantly between the JME and control groups. The 
age at seizure onset was 11–15, 16–20, and 21–25 years 
in 11, 14, and 2 JME patients, respectively. The disease 
duration was 2.9±2.1 years (range, 0.4–9 years). The 
proportion of newly diagnosed patient was 81%, and six 
patients (22%) had a family history of epilepsy. The 
monthly seizure rate was 2.0±3.0 (range, 0.3–10). The 
EEG revealed the presence of spontaneous or photo-
stimulated paroxysmal activity in all patients.
As indicated in Table 2, JME patients exhibit worse 
performances in list learning (p<0.01), forward and 
backward digit spans (p<0.01), TMT parts A (p<0.01) 
and B (p<0.05), and verbal fluency (p<0.01) compared 
with those of controls. However, the scores of the IQ 
test, BAI, and BDI did not differ between the two 
groups.
2. Correlation analysis
The poor performance in neuropsychological tests in 
the JME group were not correlated with age, sex, family 
history, education level, seizure frequency, EEG ab-
normality, or previous intake of AED. However, there 
were significant correlations between age at seizure 
onset and verbal fluency (r=0.481,  p<0.05) and disease 
duration and backward digit span ability (r=–0.449, 
p<0.05).
DISCUSSION
We found that intelligence and mood were similar in 
our JME patients and healthy subjects, whereas the 
former exhibited specific cognitive deficits such as 
memory and executive dysfunction. Also, their cognitive 
function was affected by age at seizure onset and duration 
of disease.
While intellectual abilities in IGE are usually within 
the normal range, they tend to be somewhat lower than 
those in the general population.
16,22 Behavioral dis-
turbances and poor social adjustment are the most 
frequently reported problems in IGE. In particular, Kim SY, et al. Cognitive Impairment in Juvenile Myoclonic Epilepsy 
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Table 2. Neuropsychological outcomes 
Measure
JME (n=27)
mean (SD)
Controls (n=27)
mean (SD)
Significance
a
List learning  60.1 (7.5) 67.9 (3.0) p<0.01
Immediate word recall  11.5 (1.0) 11.8 (0.5) NS*
Delayed word recall  11.4 (1.0) 11.8 (0.5) NS
Word recognition  11.9 (0.2) 12.0 (0.0) NS
Visual reproduction   8.5 (1.4)  8.8 (1.5) NS
Digit span, forward   9.2 (2.7) 10.9 (1.5) p<0.01
Digit span, backward   7.4 (2.3)  9.9 (2.2) p<0.01
Trail-Making Test, part A
Time (sec)  31.2 (10.9) 21.1 (5.8) p<0.01
No. of errors   0.2 (0.5)  0.0 (0.0) NS
Trail-Making Test, part B
Time (sec)  74.7 (27.5) 56.0 (25.4) p<0.05
No. of errors  0.5 (0.8)  0.1 (0.6) NS
Verbal fluency 14.7 (3.4) 21.7 (6.1) p<0.01
IQ score 97.4 (14.6) 103.2 (11.0) NS
BAI 7.8 (8.8)  7.2 (5.8) NS
BDI 8.3 (9.6)  7.5 (4.8) NS
BAI; Beck Anxiety Inventory, BDI; Beck Depression Inventory. 
at test for independent samples (two-sided).
*p>0.05. 
Higher scores indicate better performance except for the Trail-Making Test. 
patients with JME have been found to be somewhat 
immature, emotionally unstable, and disinhibited, which 
may result in inadequate social adjustment.
17  Some of 
the personality traits and difficulties in social integration 
that are seen in JME are similar to those observed in 
patients with frontal lobe lesions. Dysfunction of these 
regions, especially the prefrontal cortex, results in 
disturbances in the organization and self-regulation of 
behavior.
18 These so-called executive functions are 
complex cognitive processes that require coordination of 
several subsystems.
34  They include the ability to plan 
and to form abstract concepts, as well as the control of 
attention, impulsivity, and emotions.
3 Neuropsycho-
logical, histopathological, and neuroimaging studies 
provide strong evidence for frontal lobe dysfunction in 
JME.
4,6–9,21,27 However, studies of other cognitive areas 
are still scarce.
3
Two previous neuropsychological studies have demon-
strated the cognitive dysfunction in JME patients.
4,21 
Devinsky et al. found a high frequency of impairment of 
executive functions such as in concept formation, ab-
stract reasoning and mental flexibility, cognitive speed, 
and planning and organization.
21  However, that study 
was limited by the use of a battery of tests that are only 
sensitive to frontal dysfunction, and by comparing the 
performance on selected tests with that of patients with 
temporal lobe epilepsy. Sonmez et al. reported that JME 
patients had minimal general cognitive dysfunction, 
impaired verbal and visual memory, worse performance 
in visuospatial tests, and adverse affects in all frontal 
lobe tests.
4 However, the significance of those results 
may have been decreased by the use of JME patients 
who were taking valproate. Because adverse effects of 
AEDs can contribute to cognitive impairment, it is 
preferable to investigate epilepsy patients who are not 
receiving AED medications. Another limitation of the 
study of Sonmez et al. is that since they did not perform 
mood tests, they were not able to exclude the effects of 
mood on cognition. Depression, anxiety, and other neuro-
psychiatric sequelae are known to independently com-Journal of Clinical Neurology: Vol. 3, No. 2, 2007
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promise the integrity of mnestic processing.
24 Depression 
can affect the performance of executive functions and the 
speed of completing a screening test for cognitive 
function.
25 Because epilepsy patients can be easily 
affected by mood disorders, mood changes should be 
measured simultaneously during a cognitive study so as 
to discriminate a true cognitive dysfunction from cog-
nitive impairment due to mood changes. In the present 
study we therefore performed various cognitive tests 
including mood tests in drug-naive patients, and com-
pared the results with those of healthy subjects.
The cognitive performances of JME patients in the 
study of Sonmez et al.
4 were somewhat similar to those 
of our patients. They found significant impairments of 
verbal memory and executive function. A recent MRI 
volumetry study revealed volume changes in the frontal 
lobe and hippocampus in JME patients,
8 with the left 
hippocampus being significantly smaller than the right 
one. These structural changes might be correlated with 
the impaired performance on the list-learning test in our 
cases. Therefore, further studies elucidating memory 
deficits in JME patients are needed.
Sonmez et al. found that visual memory and visuo-
spatial function were impaired in JME patients,
4 but this 
was not the case in our study. These differences might 
be attributable to Sonmez et al. not performing mood 
tests, and hence their study not excluding the effect of 
mood on global cognitive performance. The second 
explanation is that the duration of the disease may affect 
the degree of cognition dysfunction. The psychometric 
intelligence of patients was more severely impaired for 
a duration of refractory unilateral temporal lobe epilepsy 
of more than 30 years than for one of 15–30 years.
26 
The longer mean disease duration in the study of 
Sonmez et al.
4 (7.2 years) compared with ours (2.9  
years) may have resulted in worse cognition in their 
study. Moreover, the digit span performance was intact 
in the patients of Sonmez et al.
4 but impaired in our 
patients. The digit span test measures attention and 
short-term memory capacity. Brief disruption of cog-
nitive function as a manifestation of interictal epileptiform 
discharge (IED) has been well described,
35 with it being 
reported in up to 50% of patients with subclinical 
epileptiform activity and even in patients during single- 
spike discharges. These effects can appear during tests 
of attention, verbal, or nonverbal functions.
36 IED on 
EEG was evident in all of our patients, compared with 
only 57% of the patients in the study of Sonmez et al.
4 
Therefore, a higher frequency of IED on EEG may be 
related to an impaired digit span performance.
Some studies have emphasized a decline in the 
intellectual function of epileptic patients. Lower IQ 
scores were observed in patients with a younger age at 
onset, more frequent seizures, more frequent status, 
longer duration of seizures, structural anomalies of the 
brain, and atypical absence seizures.
16,19  However, IQ 
tests tend not to be sufficiently sensitive to detect subtle 
neuropsychological changes.
37  Our study did not reveal 
any significant differences in IQ score between JME 
patients and controls despite the presence of abnormal 
memory and executive functions in the former. A sub-
stantial proportion of our patients were newly diagnosed 
and with a recent occurrence of JME. They did not have 
severe seizures or concomitant brain pathology, and 
hence these factors may not affect global intelligence.
The reported overall prevalences of depressive and 
anxiety disorders in epilepsy patients have been as high 
as 55% and 25%, respectively.
30 Despite the high 
prevalence of mood disorders in epilepsy, the results of 
our mood tests did not differ between the JME patients 
and controls. Known risk factors for depression in 
epilepsy patients include neurobiological factors, psycho-
social factors, and psychotropic effects of AEDs.
31 
Findings of bilateral inferior frontal hypometabolism in 
patients with partial epilepsy and interictal depression 
suggest a neurobiologic basis for depression.
39 However, 
since our patients had IGE, it is impossible to deduce 
whether there are neurobiologic risk factors for depression. 
Psychosocial factors such as stressful life events, poor 
adjustment to epilepsy, and lower financial status can be 
a risk factor for depression.
32 However, since our pa-
tients were of school age and had a short duration of 
disease, psychosocial factors should not have affected 
depression. Furthermore, since our patients did not take 
AEDs before the study, psychotropic effects of AEDs 
were not present. The design of our study – allowing the 
exclusion of mood affection on cognition – made it 
possible to demonstrate specific cognitive deficits in Kim SY, et al. Cognitive Impairment in Juvenile Myoclonic Epilepsy 
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JME patients.
Cognitive correlates of JME have received little 
attention despite the extensive studies of cognition in 
other types of epilepsy. Sonmez et al. found that 
younger age, presence of a family history, and absence 
seizures had negative effects on cognitive function,
4 
whereas we demonstrated the harmful effects of early 
onset of seizure and longer duration of disease. Recent 
studies have shown that cognitive dysfunction is more 
frequent in patients with a younger age at seizure 
onset.
23 Deterioration of neuropsychological functioning 
appears to be related to a longer duration of the seizure 
disorder.
26 Our findings support these relationships. Un-
fortunately, the lower incidences of a family history and 
absence seizures in our cases hindered our ability to 
demonstrate any relationship between these risks and 
cognition.
Two questions remain to be answered regarding the 
relationship between cognition and JME. First, it is 
difficult to determine whether cognitive and behavioral 
impairments in JME are caused by stable, disease-related 
factors or by the acute effects of paroxysmal epileptic 
activity, such as epileptiform EEG discharges.
33 Our 
study demonstrated the harmful effects of an early onset 
of seizure and longer duration of disease on cognition. 
These results may be consistent the theory of disease- 
related factors. However, the impaired attention in our 
patients was probably due to a high frequency of IED, 
which means that the theory of the acute effects of 
paroxysmal activity on cognition cannot be ruled out. 
Neuropsychological studies of patients who are seizure- 
free after receiving AEDs medication are needed to 
answer this question. The second unsolved question is 
whether these impairments are specific to JME or are also 
applicable to other types of IGE.
3 Future neuropsycho-
logical studies should compare the effects of various 
idiopathic epileptic syndromes with those of JME.
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